6:09 PM
 | 
Nov 12, 2012
 |  BC Extra  |  Company News

FDA accepts NDA for menopause product

FDA accepted for review an NDA from Noven Pharmaceuticals Inc. for low-dose paroxetine mesylate to...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >